In India trip, Galvez to appeal for early 2nd quarter deployment of Novavax COVID-19 vaccines

enablePagination: false
maxItemsPerPage: 10
totalITemsFound:
maxPaginationLinks: 10
maxPossiblePages:
startIndex:
endIndex:

(FILE PHOTO)

Metro Manila (CNN Philippines, March 4)— The Philippine government aims to finalize its COVID-19 vaccine supply agreement with Novavax — and will appeal for its products’ early deployment — when officials visit India this March, vaccine czar Carlito Galvez Jr. said on Thursday.

“We will [be] closing ‘yung aming supply agreement sa Novavax,” Galvez told CNN Philippines’ The Source, pertaining to his trip to the South Asian country starting March 9.

“And we are appealing na magkaroon ng early deployment ang Novavax this coming second quarter,” he added.

[Translation: We will be closing our supply agreement with Novavax. And we are appealing to have an early deployment of Novavax this coming second quarter.]

The Philippines earlier inked a term sheet to secure 30 million doses of the Covovax vaccine, which is developed by the US-based biotechnology company Novavax and manufactured at the Serum Institute of India.

READ: Novavax’s COVID-19 vaccine: What we know so far

Galvez earlier said the government was willing to shell out more funds if it means getting the coronavirus vaccines earlier. He later revealed that some Western manufacturers declined the country’s offer to pay more, but did not identify the concerned companies.

Aside from Novavax, the country is also expecting to receive more vaccine doses from AstraZeneca by the second quarter. He added negotiations with another American company Moderna are also underway.

“Hopefully, ma-close namin ‘yung supply agreement (Hopefully we can close the supply agreement),” he said.